Can the new adipokine asprosin be a metabolic troublemaker for cardiovascular diseases? A state-of-the-art review

Progress in Lipid Research - Tập 91 - Trang 101240 - 2023
Zhengbin Zhang1,2,3, Liwen Zhu4, Ziqian Wang1,3, Ning Hua1,2, Shunying Hu1, Yundai Chen1
1Senior Department of Cardiology, The Sixth Medical Centre, Chinese PLA General Hospital, 6 Fucheng Road, Beijing 100048, China
2Department of Cardiology, The Eighth Medical Centre, Chinese PLA General Hospital, 17 Heishanhu Road, Beijing 100091, China
3Chinese PLA Medical School, 28 Fuxing Road, Beijing 100853, China
4Department of Cardiology, The Fourth Medical Centre, Chinese PLA General Hospital, 51 Fucheng Road, Beijing 100048, China

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Progress in Lipid Research

Tập 91

101240

Thông tin tác giả